Panacea Life Sciences Holdings, Inc. Stock Issued During Period, Value, Acquisitions
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, acquisitions for the quarter ending 2021-12-31 was $0.00.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, acquisitions for the quarter ending 2021-09-30 was $0.00.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, acquisitions for the quarter ending 2021-06-30 was $4.38M.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, acquisitions for the quarter ending 2019-06-30 was $450.00K.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, acquisitions for fiscal 2021 was $4.38M.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, acquisitions for fiscal 2019 was $0.00.
- Panacea Life Sciences Holdings, Inc. stock issued during period, value, acquisitions for fiscal 2016 was $292.00.
| Period end | Stock Issued During Period, Value, Acquisitions 3 month | Stock Issued During Period, Value, Acquisitions 12 month |
|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $4.38M 10-K · filed 2022-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | |
| 2021-06-30 | $4.38M 10-Q · filed 2022-08-15 | |
| 2019-12-31 | $0.00 10-K/A · filed 2021-04-23 | |
| 2019-06-30 | $450.00K 10-Q · filed 2020-11-18 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-11-18 | |
| 2016-12-31 | $292.00 10-K · filed 2018-04-02 |